|
TargetMol
amg900 ![]() Amg900, supplied by TargetMol, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/amg900/product/TargetMol Average 97 stars, based on 1 article reviews
amg900 - by Bioz Stars,
2026-03
97/100 stars
|
Buy from Supplier |
|
Amgen
amg900 ![]() Amg900, supplied by Amgen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/amg900/product/Amgen Average 90 stars, based on 1 article reviews
amg900 - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
Selleck Chemicals
amg900 ![]() Amg900, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/amg900/product/Selleck Chemicals Average 93 stars, based on 1 article reviews
amg900 - by Bioz Stars,
2026-03
93/100 stars
|
Buy from Supplier |
|
ApexBio
amg900 ![]() Amg900, supplied by ApexBio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/amg900/product/ApexBio Average 90 stars, based on 1 article reviews
amg900 - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
Adooq Bioscience LLC
amg900 ![]() Amg900, supplied by Adooq Bioscience LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/amg900/product/Adooq Bioscience LLC Average 90 stars, based on 1 article reviews
amg900 - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
Cayman Chemical
amg900 (#19176) ![]() Amg900 (#19176), supplied by Cayman Chemical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/amg900 (#19176)/product/Cayman Chemical Average 90 stars, based on 1 article reviews
amg900 (#19176) - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
Journal: bioRxiv
Article Title: MYC amplifies mitotic perturbations elicited by LXY18 to enable synthetic lethality
doi: 10.1101/2023.11.07.565938
Figure Lengend Snippet: RPE-NEO and RPE-MYC cells were treated with either vehicle control (0.1% DMSO) or indicated mitotic inhibitors for 24 h before immunofluorescent staining for H3Ser10P and staining for DNA with 4’,6-diamidino-2-phenylindole (DAPI). Cells positive for H3Ser10P were scored as mitotic cells and quantified when cells were treated with compounds other than AURKB inhibitors. For cells exposed to AZD1152 and AMG900, mitotic cells were identified based on their condensed chromosomes revealed by DAPI staining. The following mitotic inhibitors were used at minimally effective concentrations that are known to inhibit their respective targets, AZD1152 (200 nM), AMG900 (10 nM), BAY1217389 (20 nM), Centrinone (1 μM), GSK923295 (40 nM), SB743921 HCl (1.25 nM), Sovilnesib (80 nM). (A) Representative immunofluorescent images. (B) The percentage of the mitotic cells. Data are presented as mean ± SD. ****p<0.0001. (C) Histograms show the ratio of the mitotic index (MI) in RPE-MYC cells relative to RPE- NEO cells.
Article Snippet: Other antimitotic agents were obtained from the following commercial sources, AZD1152 (Selleck, CAS: 722544-51-6, Cat. No. S1147),
Techniques: Staining
Journal: Frontiers in Oncology
Article Title: Beyond targeting amplified MDM2 and CDK4 in well differentiated and dedifferentiated liposarcomas: From promise and clinical applications towards identification of progression drivers
doi: 10.3389/fonc.2022.965261
Figure Lengend Snippet: Investigational drugs in well differentiated and dedifferentiated liposarcoma.
Article Snippet:
Techniques: Binding Assay
Journal: Cancer cell
Article Title: Poziotinib for EGFR exon 20 mutant NSCLC: clinical efficacy, resistance mechanisms and impact of insertion location on drug sensitivity
doi: 10.1016/j.ccell.2022.06.006
Figure Lengend Snippet: Key Resource Table
Article Snippet:
Techniques: Produced, Virus, Clinical Proteomics, Recombinant, Viability Assay, Lysis, In Vitro, In Vivo, Gene Expression, Mutagenesis, Software